Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Firms / Agent Capital, LLC

Agent Capital, LLC

Institutional venture firmWaltham, MAagentcapital.comSEC venture capital fund adviserfundraising evidence

Agent Capital is a healthcare venture capital firm focused on investing in novel, differentiated therapeutics & treatments that address unmet patient needs.

venture manager, reported GAV $131M across 3 vehicles

Importance
17
moderate
Active deployment
64
high
Emerging
0
low
Completeness
75
high
Freshness
99
high
Research priority
18
moderate
Identity and regulatory footprint
Headquarters
Waltham, MAadviserinfo.sec.gov
Office address
1400 MAIN STREET, FLOOR 1, Waltham, MA, 02451adviserinfo.sec.gov
Business phone
847-691-6233adviserinfo.sec.gov
SEC adviser type
exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
Latest Form ADV
Apr 6, 2026
Private funds reported
3 (3 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$140Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
business email
info@agentcapital.comagentcapital.compublished by the subject
business phone
847-691-6233adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
1 observed deals
Stated (the firm’s website)
Sectors
healthcare, biotech
Stages
multi stage
Geography
not stated
Check size
not stated; DFX does not estimate checks from round sizes
Self-described
venture capital
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 100%
lead rate n/afollow-on rate n/anew logos, 12 months 1
Funds and vehicles
3 reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
Agent Capital Fund III LPFund2024 form d first saleFundraisingunknownunknown$53.3M
of $100M
Feb 18, 2026
Agent Capital Fund II LPFund2021 form d first saleMature$82.0M
Mar 18, 2024
22$59.5M
of $100M
Aug 3, 2021
Agent Capital Fund I LPFund2017 form d first saleHarvest$49.2M
Mar 18, 2024
10$61.3M
of $61.3M
Nov 20, 2019
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
2 current, 1 departed
Investments on record
1 edges, 1 companies, 0 partner-attributed
CompanyRoundRolePartnerRound sizeThis investorDateSource
Ashibioportfolio listingunknownunknownunknownunknownSep 13, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
1 relationships from shared deals, counted for the whole firm
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
4 dated events
  1. Mar 10, 2022
    Agent Capital Fund II LP first reported on Form ADV by Agent Capital, LLC (Venture Capital Fund), GAV $59,097,544
  2. Mar 11, 2020
    Marta New (Member) no longer on Schedule A of Agent Capital, LLC
  3. Jun 26, 2017
    Agent Capital, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)
  4. Jun 26, 2017
    Agent Capital Fund I LP first reported on Form ADV by Agent Capital, LLC (Venture Capital Fund), GAV $27,337,500
Classification history
  1. Sep 12, 2026
    Institutional venture firm (confirmed, 95%, cls-1)
    venture manager, reported GAV $131M across 3 vehicles
Evidence
50 observations from 3 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
Why admittedvc_exemption,vc_funds_reportedApr 6, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC exemption claimedventure_capital_fund_adviserApr 6, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC exemption claimedventure_capital_fund_adviserMar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC adviser typeexempt_reporting_adviserApr 6, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC adviser typeexempt_reporting_adviserMar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2017-06-26Mar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2026-04-06Apr 6, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Latest Form ADV filing2024-03-18Mar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC statusERA - ActiveApr 6, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC status effective2017-06-26Apr 6, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture share of reported funds1Mar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone847-691-6233Apr 6, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Business phone847-691-6233Mar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Contact page urlhttps://www.agentcapital.com/contact/
contact page linked from the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
DescriptionAgent Capital is a healthcare venture capital firm focused on investing in novel, differentiated therapeutics & treatments that address unmet patient needs.
meta description
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
DescriptionAgent Capital is a healthcare venture capital firm focused on investing in novel, differentiated therapeutics & treatments that address unmet patient needs.
meta description
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
HeadquartersWaltham, MAApr 6, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
HeadquartersWaltham, MAMar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office address1400 MAIN STREET, FLOOR 1, Waltham, MA, 02451Apr 6, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Office address1400 MAIN STREET, FLOOR 1, Waltham, MA, 02451Mar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Self-described typeventure_capital
Agent Capital | Healthcare Venture Capital Firm | Biotechnology
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Self-described typeventure_capital
Agent Capital | Healthcare Venture Capital Firm | Biotechnology
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Legal formLimited Liability CompanyApr 6, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Legal formLimited Liability CompanyMar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Portfolio pagehttps://www.agentcapital.com/portfolio/
0 entries read
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Portfolio pagehttps://www.agentcapital.com/portfolio/
1 entries read
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Private funds reported3Apr 6, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private funds reported2Mar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$140MApr 6, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private fund gross assets (reported)$131MMar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Stated sectorshealthcare,biotech
sector words on the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorshealthcare,biotech
sector words on the home page
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated stagesmulti_stage
stage words on the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated stagesmulti_stage
stage words on the home page
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Venture funds reported3Apr 6, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture funds reported2Mar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
WebsiteHTTPS://WWW.AGENTCAPITAL.COMApr 6, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
WebsiteHTTPS://WWW.AGENTCAPITAL.COMMar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Site titleAgent Capital | Healthcare Venture Capital Firm | Biotechnology
title tag
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Site titleAgent Capital | Healthcare Venture Capital Firm | Biotechnology
title tag
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)